The pro-form of BMP-2 exhibits a delayed and reduced activity when compared to mature BMP-2

Growth Factors

Volumn 29, Issue 2-3, 2011, Pages 63-71

  Von Einem, Sabrina ^a   Erler, Silvio ^a   Bigl, Katrin ^b   Frerich, Bernhard ^b   Schwarz, Elisabeth ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

alkaline phosphatase; Bone morphogenetic protein 2; internalization; pro form; processing

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; GROWTH FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; MICE; OSTEOBLASTS; OSTEOCALCIN; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 79955850865     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2011.561798     Document Type: Article

References (32)

1. Althaus HH, Kloppner S. 2006. Mature pig oligodendrocytes rapidly process human recombinant pro-nerve growth factor and do not undergo cell death. J Neurochem 98:506-517. (Pubitemid 44133154)
2. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217-224. (Pubitemid 36163863)
3. Benglis D, Wang MY, Levi AD. 2008. A comprehensive review of the safety profile ofbone morphogenetic protein in spine surgery. Neurosurgery 62:ONS423-31; discussion ONS431.
4. Boutilier J, Ceni C, Pagdala PC, Forgie A, Neet KE, Barker PA. 2008. Proneurotrophins require endocytosis and intracellular proteolysis to induce TrkA activation. J Biol Chem 283: 12709-12716.
5. Cao X, Chen D. 2005. The BMP signaling and in vivo bone formation. Gene 357:1-8. (Pubitemid 41267309)
6. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y Arbel R, et al. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123-2134. (Pubitemid 35417689)
7. Gray AM, Mason AJ. 1990. Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly. Science 247:1328-1330.
8. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bachinger HP, Sakai LY. 2005. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280:27970-27980. (Pubitemid 41076914)
9. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P. 2006. Different routes of bone morphogenic protein (BMP) receptor endocy-tosis influence BMP signaling. Mol Cell Biol 26:7791-7805. (Pubitemid 44547724)
10. Hauburger A, von Einem S, Schwaerzer GK, Buttstedt A, Zebisch M, Schraml M, Hortschansky P, Knaus P, Schwarz E. 2009. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. Febs J 276: 6386-6398.
11. Hillger F, Herr G, Rudolph R, Schwarz E. 2005. Biophysical comparison of BMP-2. ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. J Biol Chem 280:14974-14980. (Pubitemid 40562849)
12. Jones WK, Richmond EA, White K, Sasak H, Kusmik W, Smart J, Oppermann H, Rueger DC, Tucker RF. 1994. Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: Isolation of a soluble complex containing the mature and pro-domains ofOP-1. Growth Factors 11:215-225.
13. Jortikka L, Laitinen M, Lindholm TS, Marttinen A. 1997. Internalization and intracellular processing ofbone morphogen-etic protein (BMP) in rat skeletal muscle myoblasts (L6). Cell Signal 9:47-51. (Pubitemid 27120865)
14. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH. 1990. TGF-beta 1 binding protein: A component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell 61: 1051-1061.
15. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755-1766. (Pubitemid 24380911)
16. Martinez-Arca S, Bech-Serra JJ, Hurtado-Kuttner M, Borroto A, Arribas J. 2005. Recycling of cell surface pro-transforming growth factor-{alpha} regulates epidermal growth factor receptor activation. J Biol Chem 280:36970-36977. (Pubitemid 41587780)
17. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
18. Nohe A, Keating E, Knaus P, Petersen NO. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299. (Pubitemid 37542404)
19. Pereira CT, Huang W, Jarrahy R, Rudkin G, Yamaguchi DT, Miller TA. 2009. Human and mouse osteoprogenitor cells exhibit distinct patterns of osteogenesis in three-dimensional tissue engineering scaffolds. Plast Reconstr Surg 124:1869-1879.
20. Sebald W, Nickel J, Zhang JL, Mueller TD. 2004. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem 385:697-710. (Pubitemid 39255628)
21. Shanmugarajan S, Tsuruga E, Swoboda KJ, Maria BL, Ries WL, Reddy SV. 2009. Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy J Pathol 219:52-60.
22. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. 2006. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31:542-547.
23. Simic P, Vukicevic S. 2007. Bone morphogenetic proteins: From developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Rep 8:327-331. (Pubitemid 46511031)
24. Sopory S, Nelsen SM, Degnin C, Wong C, Christian JL. 2006. Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain. J Biol Chem 281: 34021-34031. (Pubitemid 46036611)
25. Urist MR. 1965. Bone: Formation by autoinduction. Science 150: 893-899.
26. von Einem S, Schwarz E, Rudolph R. 2010. A novel TWO-STEP renaturation procedure for efficient production of recombinant BMP-2. Protein Expr Purif73:65-69.
27. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, WozneyJM. 1988. Purification and characterization ofother distinct bone-inducing factors. Proc Natl Acad Sci USA 85:9484-9488. (Pubitemid 19027155)
28. Wozney JM. 1992. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167.
29. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators ofbone formation: Molecular clones and activities. Science 242: 1528-1534. (Pubitemid 19023695)
30. Yamashita H, Ten Dijke P, Heldin CH, Miyazono K. 1996. Bone morphogenetic protein receptors. Bone 19:569-574. (Pubitemid 27035834)
31. Yanai T, Katagiri T, Akiyama S, Imada M, Yamashita T, Chiba H, Takahashi N, Suda T 2001. Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures. J Bone Miner Metab 19: 345-351. (Pubitemid 33041727)
32. Yoon BS, Lyons KM. 2004. Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93:93-103.